Enzyme Technologies Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
2
Enzyme Technologies General Information
Description
Manufacturer of bromelain enzyme intended to serve the food and beverage, animal health, human health, nutraceuticals, and cosmetics industries. The company offers a wide range of bromelain products produced by isolating it from pineapples, which derive health benefits such as improved digestion, anti-inflammatory properties, and support for wound healing, as well as acting as a natural blood thinner and offering other benefits, thereby delivering environmentally and economically beneficial products while adhering to pharmaceutical standards.
Contact Information
Website
www.bromelainsa.co.zaCorporate Office
- 1 Dickens Road
- Building 318, Umbogintwini Industrial Complex (Northgate)
- Umbogintwini, 4126
- South Africa
Corporate Office
- 1 Dickens Road
- Building 318, Umbogintwini Industrial Complex (Northgate)
- Umbogintwini, 4126
- South Africa
Enzyme Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Enzyme Technologies FAQs
-
When was Enzyme Technologies founded?
Enzyme Technologies was founded in 2006.
-
Where is Enzyme Technologies headquartered?
Enzyme Technologies is headquartered in Umbogintwini, South Africa.
-
What industry is Enzyme Technologies in?
Enzyme Technologies’s primary industry is Biotechnology.
-
Is Enzyme Technologies a private or public company?
Enzyme Technologies is a Private company.
-
What is Enzyme Technologies’s current revenue?
The current revenue for Enzyme Technologies is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process